THOR Share Price

Open 63.49 Change Price %
High 63.50 1 Day 0.05 0.08
Low 63.47 1 Week 0.00 0.00
Close 63.50 1 Month 0.00 0.00
Volume 2366422 1 Year 0.00 0.00
52 Week High 1.48
52 Week Low 0.21
THOR Important Levels
Resistance 2 63.53
Resistance 1 63.52
Pivot 63.49
Support 1 63.48
Support 2 63.47
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

Thoratec Corporation (NASDAQ: THOR)

THOR Technical Analysis 5
As on 8th Oct 2015 THOR Share Price closed @ 63.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 44.52 & Strong Buy for SHORT-TERM with Stoploss of 62.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
THOR Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
THOR Other Details
Segment EQ
Market Capital 2109961088.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.thoratec.com
THOR Address
THOR
6035 Stoneridge Drive
Pleasanton, CA 94588
United States
Phone: 925-847-8600
THOR Latest News
St. Jude Medical (STJ) Announces Completion of $3.3B Thoratec Acquisition   StreetInsider.com   - 09th Oct 15
Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec   PR Newswire (press release)   - 08th Oct 15
Biotech Opportunities Today: Intuitive Surgical (ISRG), Exelixis (EXEL ...   CNA Finance (press release)   - 22nd Jul 15
St. Jude Medical to Buy Thoratec for $3.4 Billion   New York Times   - 22nd Jul 15
Insider Trade: Neil Dimick Unloaded 4786 Shares of Thoratec Corporation ...   OctaFinance.com   - 14th Apr 15
Thoratec Corp. expanding its operations   Woburn Daily Times   - 12th Mar 14
Thoratec And The War In Heart Pumps   Seeking Alpha   - 09th Jul 13
Thoratec Acquires DuraHeartĀ® II Ventricular Assist System   PR Newswire (press release)   - 01st Jul 13
Thoratec Stays One Beat Ahead Of The Rest   Seeking Alpha   - 31st Dec 12
Thoratec Corporation Names Gary Burbach President and Chief Executive Officer   PR Newswire (press release)   - 17th Jan 06
Interactive Technical Analysis Chart Thoratec Corporation ( THOR NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Thoratec Corporation
THOR Business Profile
Thoratec Corporation is engaged in mechanical circulatory support with a product portfolio to treat the range of clinical needs for advanced heart failure (HF) patients. The Company develops, manufactures and markets medical devices used for circulatory support. For advanced HF, its primary product lines are its ventricular assist devices (VADs), which include the Thoratec Paracorporeal Ventricular Assist Device (PVAD), the Thoratec Implantable Ventricular Assist Device (IVAD), the HeartMate Left Ventricular Assist System (HeartMate XVE), and the HeartMate II Left Ventricular Assist System (HeartMate II). For acute HF, its product lines are the CentriMag Acute Circulatory System (CentriMag) and for pediatric patients the PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). On August 3, 2011, the Company acquired Levitronix LLC (Levitronix). During the year ended December 31, 2011, the Company discontinued the sale of the HeartMate XVE.